… Because COVID-19 patients are known to have an excessive … examine circulating cytokines
in plasma samples of COVID-19-… cytokines for a more in depth understanding of the cytokine …

… pathway downstream of ACE2 could lead to cytokine release syndrome as observed in
COVID-19 patients that may require targeting of cytokine pathways, particularly IL-6-STAT3 axis. …

… The current study does not support blocking IL-1 or IL-6 in patients with COVID-19, but
more research is needed to determine whether subgroups of patients might benefit or other …

… syndrome (COVID-19), which is fatal in many cases, and is characterized by a cytokine release
syndrome (CRS… of pro-inflammatory cytokines in order to control this “cytokine storm” and …

… COVID-19 infection-related CRS. Our results demonstrate that IL-6 was an early indicator of
CRS in COVID-19… an effective method to treat COVID-19 pneumonia patients with CRS and …

… response during coronavirus disease (COVID-19) can induce cytokine release syndrome
(CRS), which is associated with life-threatening complications and disease progression. This …

… that outcomes were chiefly driven by a cytokine release syndrome (CRS). … with COVID-19
who were recruited in our transplant center between March 4 and April 7, 2020. COVID-19 was …

… patients, several drugs are under trials to control the cytokine storm. In this review, … of cytokine
storms in COVID-19 patients. Hitherto, several promising candidates such as IL-1 and IL-6 …

… to have COVID‐19 CSS had markedly elevated IL‐6 levels, … serum IL‐6 values reported in
a patient with COVID‐19 (Fig 1)… COVID‐19 with ARDS recorded extreme elevations of IL‐6 in …

… Our results suggest that CRS-related cytokines are commonly induced after COVID-19
vaccination and are not sufficient to establish the diagnosis of CRS. Clinically relevant CRS …